Sharon Pitt
Family · Missouri Valley, IANPI 1326443342
Payments from drug & device makers
Across 128 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$320
- AbbVie$274
- Novo Nordisk$246
- AstraZeneca$244
- Bayer$211
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$113
- plus $770 from 17 others
What the payments were for
- Food & beverage$2,179100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 20 | $320 |
| AbbVie | 13 | $274 |
| Novo Nordisk | 15 | $246 |
| AstraZeneca | 15 | $244 |
| Bayer | 12 | $211 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $113 |
| Astellas Pharma US Inc | 6 | $96 |
| Vertex | 4 | $79 |
| Mylan Specialty L.p. | 5 | $78 |
| Merck | 4 | $58 |
| Pfizer | 4 | $57 |
| Amgen | 4 | $56 |
| Organon | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $44 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $40 |
| Boehringer Ingelheim | 2 | $39 |
| Viatris Specialty LLC | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| GSK | 1 | $12 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
How this compares
$2,179 in reported general payments places this provider in the 90th percentile of 1,268 family providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 61 | $64,363 |
| JardianceEmpagliflozin | 87 | $57,507 |
| MounjaroTirzepatide | 34 | $42,763 |
| TrulicityDulaglutide | 30 | $31,704 |
| KerendiaFinerenone | 37 | $29,725 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $26,942 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 25 | $19,688 |
| RybelsusSemaglutide | 14 | $18,726 |
| EliquisApixaban | 22 | $17,386 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $12,883 |
| FarxigaDapagliflozin Propanediol | 15 | $10,995 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $8,302 |
| XareltoRivaroxaban | 18 | $7,372 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $4,525 |
| Xtampza ErOxycodone Myristate | 13 | $3,657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $246 | $83,09075 claims |
| Lilly USA, LLCMounjaro, Trulicity | $320 | $74,46764 claims |
| Boehringer IngelheimJardiance | $39 | $57,50787 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $12 | $39,82551 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $244 | $35,20956 claims |
| BayerKerendia | $211 | $29,72537 claims |
| PfizerEliquis | $57 | $17,38622 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,268 family providers in Iowa.
Other family in Missouri Valley
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.